Emergent BioSolutions (EBS) Acquisitions (2013 - 2015)
Emergent BioSolutions (EBS) posted Acquisitions of $650000.0 for Q4 2015, down 46.37% on a QoQ basis from $1.2 million in Q4 2014, and down 46.37% year-over-year from $1.2 million in Q4 2014.
Powered by 
Analysis
Emergent BioSolutions (EBS) Acquisitions (2013 - 2015) Analysis & Trends
Emergent BioSolutions has reported Acquisitions for 3 years, with the latest figure at $650000.0 in Q4 2015.
- On a quarterly basis, Acquisitions fell 46.37% year-over-year to $650000.0 in Q4 2015; TTM through Dec 2016 was $650000.0, a 0.0% change from a year earlier, with the FY2018 full-year figure at $827.7 million, up 604.43% from the prior year.
- Acquisitions was $650000.0 for Q4 2015 at Emergent BioSolutions, down from $1.2 million in the prior quarter.
- The five-year high for Acquisitions was $178.2 million in Q1 2014, with the low at $650000.0 in Q4 2015.
- Average Acquisitions over 3 years is $41.2 million, with a median of $1.8 million recorded in 2013.
- The sharpest annual moves came in 2014 and 2015: Acquisitions plunged 30.86% in 2014, then slumped 46.37% in 2015.
- Over 3 years, Acquisitions stood at $1.8 million in 2013, then slumped by 30.86% to $1.2 million in 2014, then plunged by 46.37% to $650000.0 in 2015.
- The last three Acquisitions figures came in at $650000.0 (Q4 2015), $1.2 million (Q4 2014), and $178.2 million (Q1 2014), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | -17.24 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | - |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | -23.00 Mn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 91.00 Mn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | - |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | - |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 650,000.00 |
| Dec 31, 2014 | 1.21 Mn |
| Mar 31, 2014 | 178.17 Mn |
| Dec 31, 2013 | 1.75 Mn |
| Sep 30, 2013 | 24.12 Mn |
API Access
Emergent BioSolutions Acquisitions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=acquisitions&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "acquisitions", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=acquisitions&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();